Q BioMed Inc., a biomedical acceleration and development company, along with researchers at Washington University in St. Louis have begun evaluating the feasibility of GDF-15, a novel biomarker for monitoring glaucoma, as a companion diagnostic to a small molecule...
Denis Corin has spent the last 13 years in the biopharmaceutical industry watching and learning from scientists and companies that fail. “I’ve seen so many promising and innovative young technologies really struggle along or die on the vine because they’re run by...
